Peer-reviewed veterinary case report
Mannanoligosaccharides help treat gastroenteritis and E.coli in young
By Gouveia, Eliana Maria Ferreira et al.·Published in Acta cirurgica brasileira·2006·Federal University of Mato Grosso do Sul, Brazil·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Use of mannanoligosacharides as an adjuvant treatment for gastrointestinal diseases and their effects on E.coli inactivated in dogs.
- Species:
- dog
Plain-English summary
A group of 16 young dogs, aged 2 to 6 months, suffering from gastroenteritis (inflammation of the stomach and intestines) were treated with either standard medications or those medications plus mannanoligosaccharides, a type of sugar that can help gut health. The dogs receiving mannanoligosaccharides showed a significant improvement, with 85% of them eliminating harmful E. coli bacteria from their system, compared to only 25% in the group that did not receive this supplement. This suggests that mannanoligosaccharides can be a helpful addition to the treatment of gastroenteritis in dogs, aiding in their recovery.
People also search for: dog gastroenteritis treatment · mannanoligosaccharides for dogs · E. coli in dogs symptoms
Abstract
PURPOSE: To evaluate the effects of mannanoligosacharides on dogs showing gastroenteritis. METHODS: Sixteen dogs, 2-6 month-old, distributed into two groups: T1--animals with gastroenteritis receiving treatment for the disease + mannanoligosacharides (2 g/animal).; and T2--animals with gastroenteritis receiving just treatment for the disease. The animals were randomly included in the sample and all of them were submitted to blood and feces collection for coproculture. In the treatment for gastroenteritis antibiotic, antihemetic, vermifuge, vitamins and sorotheraphy were used. The parameters evaluated were the numbers of leucocytes, neutrophils, lymphocytes and the presence of enteropathogenic bacteria in feces. RESULTS: The mannanoligosacharides was effective in eliminating pathogenic E. coli in 85.71% of the animals, while in the no-treated group only 25% of the animals were negative to E. coli. CONCLUSION: The mannanoligosacharides is effective in the control of pathogenic E. coli and it can be indicated as an adjuvant treatment for gastroenteritis in dogs.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/17293961/